Evidence map›Paper›PMID 37805971›Full record

ArticleActa diabetologica2024

Comparison and evaluation of the 2009 and 2021 chronic kidney disease-epidemiological collaboration equations among Jordanian patients with type 2 diabetes mellitus.

Randa I Farah, Abdulrahman Alhajahjeh, Oraib Al-Farahid, Hana Abuzaid, Dana Hiasat, Rama Rayyan, Laith Bdier, Izzat AlAwwa, Kamel Ajlouni

Abstract read
PubMed Publisher
In one paragraph

Article in Acta diabetologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Randa I FarahNephrology Division, Department of Internal Medicine, School of Medicine, University of Jordan, Amman, 11942, Jordan. r.farah@ju.edu.jo.ORCID http://orcid.org/0000-0003-1638-9017
Abdulrahman AlhajahjehSchool of Medicine, University of Jordan, Amman, Jordan.
Oraib Al-FarahidThe National Center for Diabetes, Endocrinology and Genetic (NCDEG), The University of Jordan, Amman, Jordan.
Hana AbuzaidThe National Center for Diabetes, Endocrinology and Genetic (NCDEG), The University of Jordan, Amman, Jordan.
Dana HiasatThe National Center for Diabetes, Endocrinology and Genetic (NCDEG), The University of Jordan, Amman, Jordan.
Rama RayyanSchool of Medicine, University of Jordan, Amman, Jordan.
Laith BdierSchool of Medicine, University of Jordan, Amman, Jordan.
Izzat AlAwwaNephrology Division, Department of Internal Medicine, School of Medicine, University of Jordan, Amman, 11942, Jordan.
Kamel AjlouniThe National Center for Diabetes, Endocrinology and Genetic (NCDEG), The University of Jordan, Amman, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study compared the 2009 versus 2021 chronic kidney disease (CKD) Epidemiological Collaboration (CKD-EPI) equations to calculate estimated glomerular filtration rate (eGFR) among Jordanian patients with T2DM to assess their agreement and impact on CKD staging.

methodsThis cross-sectional study included 2382 adult Jordanian patients with T2DM. The 2009 and 2021 CKD-EPI equations were used to calculate eGFR. Patients were reclassified according to kidney disease-Improving Global Outcomes (KDIGO) categories. Agreement between the equations was assessed using Bland-Altman plots and Lin's concordance correlation.

resultsThe 2021 equation significantly increased eGFR by a median of 2.1 mL/min/1.73 m

conclusionsAlthough there was significant agreement with the 2009 equation, the 2021 equation increased eGFR and resulted in the reclassification of a subset of subjects according to KDIGO criteria. The uncertain impact of reducing high-risk category patients raises concerns about potential delays in referral and intervention, while holding the potential to enhance high-risk patient categorization, thus alleviating healthcare burden.

Indexed as

Diabetes Mellitus, Type 2Renal Insufficiency, ChronicAdultCreatinineCross-Sectional StudiesGlomerular Filtration RateHumansJordanCreatinineChronic kidney diseaseCreatinineDisease progressionEstimated glomerular filtration rateRisk assessmentStagingType 2 diabetes mellitus

Identifiers

PMID37805971

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.